Citadel Advisors’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-296
| Closed | -$3.05K | – | 15674 |
|
|
2023
Q3 | $3.05K | Sell |
296
-119,100
| -100% | -$1.13M | ﹤0.01% | 13635 |
|
|
2023
Q2 | $985K | Buy |
119,396
+111,207
| +1,358% | +$666K | ﹤0.01% | 6483 |
|
|
2023
Q1 | $45.8K | Buy |
+8,189
| New | +$46.9K | ﹤0.01% | 12274 |
|
|
2022
Q4 | – | Sell |
-39,833
| Closed | -$164K | – | 15695 |
|
|
2022
Q3 | $192K | Sell |
39,833
-276,888
| -87% | -$1.19M | ﹤0.01% | 10446 |
|
|
2022
Q2 | $814K | Buy |
316,721
+167,003
| +112% | +$626K | ﹤0.01% | 7503 |
|
|
2022
Q1 | $862K | Buy |
+149,718
| New | +$1.34M | ﹤0.01% | 8044 |
|
|
2021
Q4 | – | Sell |
-149,898
| Closed | -$2.73M | – | 15103 |
|
|
2021
Q3 | $3.93M | Buy |
149,898
+47,752
| +47% | +$1.76M | ﹤0.01% | 4789 |
|
|
2021
Q2 | $5.11M | Buy |
102,146
+46,502
| +84% | +$2.08M | ﹤0.01% | 4379 |
|
|
2021
Q1 | $2.56M | Buy |
55,644
+24,186
| +77% | +$1.15M | ﹤0.01% | 5805 |
|
|
2020
Q4 | $1.35M | Sell |
31,458
-399
| -1% | -$15.1K | ﹤0.01% | 6156 |
|
|
2020
Q3 | $1.3M | Buy |
+31,857
| New | +$1.59M | ﹤0.01% | 5551 |
|
|
2020
Q2 | – | Sell |
-26,047
| Closed | -$1.49M | – | 10690 |
|
|
2020
Q1 | $1.36M | Buy |
+26,047
| New | +$1.41M | ﹤0.01% | 4790 |
|
|
2019
Q4 | – | Sell |
-14,293
| Closed | -$669K | – | 9949 |
|
|
2019
Q3 | $785K | Buy |
+14,293
| New | +$818K | ﹤0.01% | 6010 |
|
|
2019
Q1 | – | Sell |
-67,725
| Closed | -$4.04M | – | 10054 |
|
|
2018
Q4 | $4.32M | Buy |
+67,725
| New | +$4.8M | ﹤0.01% | 2996 |
|
|
2018
Q3 | – | Sell |
-8,855
| Closed | -$565K | – | 9840 |
|
|
2018
Q2 | $565K | Buy |
8,855
+2,832
| +47% | +$139K | ﹤0.01% | 6172 |
|
|
2018
Q1 | $234K | Sell |
6,023
-6,149
| -51% | -$215K | ﹤0.01% | 7107 |
|
|
2017
Q4 | $341K | Buy |
+12,172
| New | +$357K | ﹤0.01% | 6243 |
|
Other funds holding TRHC
Citadel Advisors's TRHC Position: Q4 2023 in Review
Citadel Advisors sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 296 shares — an estimated $3.05K sold.
Citadel Advisors first reported a position in TRHC in Q4 2017 and held it in 17 quarters. The position peaked at $5.11M in Q2 2021. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- Citadel Advisors reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 296 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $3.05K.
- Citadel Advisors first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
- Citadel Advisors's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $5.11M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.